Aurobindo Pharma Limited — Updates, 24-02-2026: Incorporation
24-02-2026 | 04:28 pm
24-02-2026 | 04:28 pm
Aurobindo Pharma incorporated Engenra Biologics Private Limited, a new wholly-owned subsidiary, with an initial capital of Rs 0.1 Cr. This move aims to expand their contract manufacturing and other pharmaceutical operations.
No comments yet. Be the first to comment!
